These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 25985005)

  • 1. Periostin: a potential target for glioblastoma multiforme treatment.
    Cavaleri JM; Monaco EA
    Neurosurgery; 2015 Jun; 76(6):N17-9. PubMed ID: 25985005
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect.
    Velpula KK; Bhasin A; Asuthkar S; Tsung AJ
    Cancer Res; 2013 Dec; 73(24):7277-89. PubMed ID: 24148623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro split-dose recovery of glioblastoma multiforme.
    Taghian A; Gioioso D; Budach W; Suit H
    Radiat Res; 1993 Apr; 134(1):16-21. PubMed ID: 8386388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
    Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
    Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of vitamins K1, K2 and K3 effects on growth of rat glioma and human glioblastoma multiforme cells in vitro.
    Oztopçu P; Kabadere S; Mercangoz A; Uyar R
    Acta Neurol Belg; 2004 Sep; 104(3):106-10. PubMed ID: 15508263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme.
    Maroon J; Bost J; Amos A; Zuccoli G
    J Child Neurol; 2013 Aug; 28(8):1002-8. PubMed ID: 23670248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration.
    Goldberg L; Kloog Y
    Cancer Res; 2006 Dec; 66(24):11709-17. PubMed ID: 17178866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.
    Lehrer S
    Med Hypotheses; 2012 May; 78(5):657-8. PubMed ID: 22385772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme.
    Tang J; Shao W; Dorak MT; Li Y; Miike R; Lobashevsky E; Wiencke JK; Wrensch M; Kaslow RA; Cobbs CS
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2040-4. PubMed ID: 16103458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies.
    Jarboe JS; Johnson KR; Choi Y; Lonser RR; Park JK
    Cancer Res; 2007 Sep; 67(17):7983-6. PubMed ID: 17804706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes.
    Jelluma N; Yang X; Stokoe D; Evan GI; Dansen TB; Haas-Kogan DA
    Mol Cancer Res; 2006 May; 4(5):319-30. PubMed ID: 16687487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma multiforme: overview of current treatment and future perspectives.
    Anton K; Baehring JM; Mayer T
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):825-53. PubMed ID: 22794286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma.
    Westhoff MA; Zhou S; Nonnenmacher L; Karpel-Massler G; Jennewein C; Schneider M; Halatsch ME; Carragher NO; Baumann B; Krause A; Simmet T; Bachem MG; Wirtz CR; Debatin KM
    Mol Cancer Res; 2013 Dec; 11(12):1611-23. PubMed ID: 24145173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
    Simpson L; Galanis E
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma multiforme and cerebral cavernous malformations: intersection of pathophysiologic pathways.
    Mian MK; Nahed BV; Walcott BP; Ogilvy CS; Curry WT
    J Clin Neurosci; 2012 Jun; 19(6):884-6. PubMed ID: 22099074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracranial metastases of glioblastoma multiforme confirmed by electron microscopy.
    O'Conner W; Challa V; Nelson O; Gotlieb S
    Surg Neurol; 1977 Nov; 8(5):347-9. PubMed ID: 199955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The methionine synthase polymorphism c.2756A>G alters susceptibility to glioblastoma multiforme.
    Semmler A; Simon M; Moskau S; Linnebank M
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2314-6. PubMed ID: 17119065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
    Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of megavolt radiation therapy on glioblastoma multiforme].
    Iashinskas PK; Ragaĭshene VN; Cheponis II
    Vopr Neirokhir; 1976; (1):41-6. PubMed ID: 176816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.
    Mao JM; Liu J; Guo G; Mao XG; Li CX
    Biomark Res; 2015; 3():8. PubMed ID: 26085929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.